Search research articles
Contact Us
Filters
Showing results (71-80 of 114) with videos related to
Page
of 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 6, 2001
A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels
L Benboubker, C Valat, C Linassier, et al.
European Journal of Haematology
|
February 13, 2001
Multiple myeloma in elderly patients: presenting features and outcome
P Rodon, C Linassier, J B Gauvain, et al.
Bone Marrow Transplantation
|
February 1, 1994
Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients
P Colombat, D Donadio, L Fouillard, et al.
Cancer Detection and Prevention
|
January 1, 1996
Value of autologous bone marrow transplantation (ABMT) in 42 patients with follicular lymphomas responsive to conventional chemotherapy: a "France Autogreffe" study
C Linassier, L Fouillard, N Milpied, et al.
Blood
|
September 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind placebo-controlled trial
N C Gorin, B Coiffier, M Hayat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
VAD-PECC regimen in the treatment of advanced-stage multiple myeloma
M Delain, C Linassier, C Petitdidier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1991
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia
P Fenaux, G Tertian, S Castaigne, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1985
[Treatment of malignant hemopathies with aracytine in low doses. Analysis of 159 cases]
S Castaigne, H Tilly, F Sigaux, et al.
Presse Medicale (Paris, France : 1983)
|
January 30, 1993
[Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas]
N C Gorin, B Coiffier, M Hayat, et al.
Leukemia & Lymphoma
|
June 28, 2001
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphoma
G Cartron, L Voillat, B Desablens, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 114) with videos related to
Sort By:
Page
of 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 6, 2001
A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels
L Benboubker, C Valat, C Linassier, et al.
European Journal of Haematology
|
February 13, 2001
Multiple myeloma in elderly patients: presenting features and outcome
P Rodon, C Linassier, J B Gauvain, et al.
Bone Marrow Transplantation
|
February 1, 1994
Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients
P Colombat, D Donadio, L Fouillard, et al.
Cancer Detection and Prevention
|
January 1, 1996
Value of autologous bone marrow transplantation (ABMT) in 42 patients with follicular lymphomas responsive to conventional chemotherapy: a "France Autogreffe" study
C Linassier, L Fouillard, N Milpied, et al.
Blood
|
September 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind placebo-controlled trial
N C Gorin, B Coiffier, M Hayat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
VAD-PECC regimen in the treatment of advanced-stage multiple myeloma
M Delain, C Linassier, C Petitdidier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1991
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia
P Fenaux, G Tertian, S Castaigne, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1985
[Treatment of malignant hemopathies with aracytine in low doses. Analysis of 159 cases]
S Castaigne, H Tilly, F Sigaux, et al.
Presse Medicale (Paris, France : 1983)
|
January 30, 1993
[Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas]
N C Gorin, B Coiffier, M Hayat, et al.
Leukemia & Lymphoma
|
June 28, 2001
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphoma
G Cartron, L Voillat, B Desablens, et al.
Page
of 12